ABSTRACT
BACKGROUND: The American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD)/International Diabetes Federation (IDF)/IFCC Consensus Statement on the worldwide standardization of HbA(1c) states that "... [HbA(1c)] results are to be reported world-wide in IFCC units ... and derived NGSP units ... , using the IFCC-NGSP master equation." METHODS: We describe statistical methods to evaluate and monitor the relationships as expressed in master equations (MEs) between the IFCC Reference Measurement procedure (IFCC-RM) and designated comparison methods (DCMs) [US National Glycohemoglobin Standardization Program (NGSP), Japanese Diabetes Society/Japanese Society for Clinical Chemistry (JDS/JSCC), and Mono-S in Sweden]. We applied these statistics, including uncertainty calculations, to 12 studies in which networks of reference laboratories participated, operating the IFCC-RM and DCMs. RESULTS: For NGSP and Mono-S, slope, intercept, and derived percentage HbA(1c) at the therapeutic target show compliance with the respective MEs in all 12 studies. For JDS/JSCC, a slight deviation is seen in slope and derived percentage HbA(1c) in 2 of the 12 studies. Using the MEs, the uncertainty in an assigned value increases from 0.42 mmol/mol HbA(1c) (IFCC-RM) to 0.47 (NGSP), 0.49 (JDS/JSCC), and 0.51 (Mono-S). CONCLUSIONS: We describe sound statistical methods for the investigation of relations between networks of reference laboratories. Application of these statistical methods to the relationship between the IFCC-RM and DCMs in the US, Japan, and Sweden shows that they are suitable for the purpose, and the results support the applicability of the ADA/EASD/IDF/IFCC Consensus Statement on HbA1c measurement.
Subject(s)
Clinical Chemistry Tests/statistics & numerical data , Data Interpretation, Statistical , Diabetes Mellitus/blood , Glycated Hemoglobin/analysis , Clinical Chemistry Tests/methods , Clinical Chemistry Tests/standards , Humans , Japan , National Health Programs , Practice Guidelines as Topic , Reference Standards , Sweden , Uncertainty , United StatesABSTRACT
The uncertainty of the results from calibrators and controls is an important component of the overall uncertainty of the results of medical samples. The purpose of this note is to review procedures of standardization and to describe the respective calculation of the uncertainty components for calibrators and controls of commercial routine diagnostic assays. The authors hope that the laying out of the procedures for uncertainty calculation of routine calibrators and controls contributes (i) to the transparency on how this component of uncertainty is derived and (ii) to a better understanding and use of the uncertainty concept in the routine laboratory.